Global Rapid Virus Diagnostic Test Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Rapid Virus Diagnostic Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Rapid Virus Diagnostic Test market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Rapid Virus Diagnostic Test global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Influenza segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Rapid Virus Diagnostic Test include BD, Abbot (Alere), Quidel, Roche, and Thermo Fisher Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Rapid Virus Diagnostic Test market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Rapid Virus Diagnostic Test product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Rapid Virus Diagnostic Test, with revenue, gross margin and global market share of Rapid Virus Diagnostic Test from 2019 to 2022.
Chapter 3, the Rapid Virus Diagnostic Test competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Rapid Virus Diagnostic Test market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Rapid Virus Diagnostic Test research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Rapid Virus Diagnostic Test market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Rapid Virus Diagnostic Test global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Influenza segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Rapid Virus Diagnostic Test include BD, Abbot (Alere), Quidel, Roche, and Thermo Fisher Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Rapid Virus Diagnostic Test market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Influenza
- RSV
- Measles
- Rubella
- HIV/HPV
- Others
- Hospitals
- POCT
- Others
- BD
- Abbot (Alere)
- Quidel
- Roche
- Thermo Fisher Scientific
- Meridian Bioscience
- Analytik Jena
- Princeton BioMeditech Corporation
- BioMerieux
- Sekisui Diagnostics
- Response Biomedical
- SA Scientific
- DiaSorin (Focus Diagnostics)
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Rapid Virus Diagnostic Test product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Rapid Virus Diagnostic Test, with revenue, gross margin and global market share of Rapid Virus Diagnostic Test from 2019 to 2022.
Chapter 3, the Rapid Virus Diagnostic Test competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Rapid Virus Diagnostic Test market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Rapid Virus Diagnostic Test research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Rapid Virus Diagnostic Test
1.2 Classification of Rapid Virus Diagnostic Test by Type
1.2.1 Overview: Global Rapid Virus Diagnostic Test Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Rapid Virus Diagnostic Test Revenue Market Share by Type in 2021
1.2.3 Influenza
1.2.4 RSV
1.2.5 Measles
1.2.6 Rubella
1.2.7 HIV/HPV
1.2.8 Others
1.3 Global Rapid Virus Diagnostic Test Market by Application
1.3.1 Overview: Global Rapid Virus Diagnostic Test Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Global Rapid Virus Diagnostic Test Market Size & Forecast
1.5 Global Rapid Virus Diagnostic Test Market Size and Forecast by Region
1.5.1 Global Rapid Virus Diagnostic Test Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Rapid Virus Diagnostic Test Market Size by Region, (2017-2022)
1.5.3 North America Rapid Virus Diagnostic Test Market Size and Prospect (2017-2028)
1.5.4 Europe Rapid Virus Diagnostic Test Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Rapid Virus Diagnostic Test Market Size and Prospect (2017-2028)
1.5.6 South America Rapid Virus Diagnostic Test Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Rapid Virus Diagnostic Test Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Rapid Virus Diagnostic Test Market Drivers
1.6.2 Rapid Virus Diagnostic Test Market Restraints
1.6.3 Rapid Virus Diagnostic Test Trends Analysis
2 COMPANY PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Rapid Virus Diagnostic Test Product and Solutions
2.1.4 BD Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 BD Recent Developments and Future Plans
2.2 Abbot (Alere)
2.2.1 Abbot (Alere) Details
2.2.2 Abbot (Alere) Major Business
2.2.3 Abbot (Alere) Rapid Virus Diagnostic Test Product and Solutions
2.2.4 Abbot (Alere) Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbot (Alere) Recent Developments and Future Plans
2.3 Quidel
2.3.1 Quidel Details
2.3.2 Quidel Major Business
2.3.3 Quidel Rapid Virus Diagnostic Test Product and Solutions
2.3.4 Quidel Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Quidel Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Rapid Virus Diagnostic Test Product and Solutions
2.4.4 Roche Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Roche Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Rapid Virus Diagnostic Test Product and Solutions
2.5.4 Thermo Fisher Scientific Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Meridian Bioscience
2.6.1 Meridian Bioscience Details
2.6.2 Meridian Bioscience Major Business
2.6.3 Meridian Bioscience Rapid Virus Diagnostic Test Product and Solutions
2.6.4 Meridian Bioscience Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Meridian Bioscience Recent Developments and Future Plans
2.7 Analytik Jena
2.7.1 Analytik Jena Details
2.7.2 Analytik Jena Major Business
2.7.3 Analytik Jena Rapid Virus Diagnostic Test Product and Solutions
2.7.4 Analytik Jena Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Analytik Jena Recent Developments and Future Plans
2.8 Princeton BioMeditech Corporation
2.8.1 Princeton BioMeditech Corporation Details
2.8.2 Princeton BioMeditech Corporation Major Business
2.8.3 Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Product and Solutions
2.8.4 Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Princeton BioMeditech Corporation Recent Developments and Future Plans
2.9 BioMerieux
2.9.1 BioMerieux Details
2.9.2 BioMerieux Major Business
2.9.3 BioMerieux Rapid Virus Diagnostic Test Product and Solutions
2.9.4 BioMerieux Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 BioMerieux Recent Developments and Future Plans
2.10 Sekisui Diagnostics
2.10.1 Sekisui Diagnostics Details
2.10.2 Sekisui Diagnostics Major Business
2.10.3 Sekisui Diagnostics Rapid Virus Diagnostic Test Product and Solutions
2.10.4 Sekisui Diagnostics Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sekisui Diagnostics Recent Developments and Future Plans
2.11 Response Biomedical
2.11.1 Response Biomedical Details
2.11.2 Response Biomedical Major Business
2.11.3 Response Biomedical Rapid Virus Diagnostic Test Product and Solutions
2.11.4 Response Biomedical Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Response Biomedical Recent Developments and Future Plans
2.12 SA Scientific
2.12.1 SA Scientific Details
2.12.2 SA Scientific Major Business
2.12.3 SA Scientific Rapid Virus Diagnostic Test Product and Solutions
2.12.4 SA Scientific Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 SA Scientific Recent Developments and Future Plans
2.13 DiaSorin (Focus Diagnostics)
2.13.1 DiaSorin (Focus Diagnostics) Details
2.13.2 DiaSorin (Focus Diagnostics) Major Business
2.13.3 DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Product and Solutions
2.13.4 DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 DiaSorin (Focus Diagnostics) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Rapid Virus Diagnostic Test Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Rapid Virus Diagnostic Test Players Market Share in 2021
3.2.2 Top 10 Rapid Virus Diagnostic Test Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Rapid Virus Diagnostic Test Players Head Office, Products and Services Provided
3.4 Rapid Virus Diagnostic Test Mergers & Acquisitions
3.5 Rapid Virus Diagnostic Test New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Rapid Virus Diagnostic Test Revenue and Market Share by Type (2017-2022)
4.2 Global Rapid Virus Diagnostic Test Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Rapid Virus Diagnostic Test Revenue Market Share by Application (2017-2022)
5.2 Global Rapid Virus Diagnostic Test Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Rapid Virus Diagnostic Test Revenue by Type (2017-2028)
6.2 North America Rapid Virus Diagnostic Test Revenue by Application (2017-2028)
6.3 North America Rapid Virus Diagnostic Test Market Size by Country
6.3.1 North America Rapid Virus Diagnostic Test Revenue by Country (2017-2028)
6.3.2 United States Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
6.3.3 Canada Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
6.3.4 Mexico Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Rapid Virus Diagnostic Test Revenue by Type (2017-2028)
7.2 Europe Rapid Virus Diagnostic Test Revenue by Application (2017-2028)
7.3 Europe Rapid Virus Diagnostic Test Market Size by Country
7.3.1 Europe Rapid Virus Diagnostic Test Revenue by Country (2017-2028)
7.3.2 Germany Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
7.3.3 France Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
7.3.5 Russia Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
7.3.6 Italy Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Rapid Virus Diagnostic Test Revenue by Type (2017-2028)
8.2 Asia-Pacific Rapid Virus Diagnostic Test Revenue by Application (2017-2028)
8.3 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Region
8.3.1 Asia-Pacific Rapid Virus Diagnostic Test Revenue by Region (2017-2028)
8.3.2 China Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8.3.3 Japan Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8.3.4 South Korea Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8.3.5 India Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8.3.7 Australia Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Rapid Virus Diagnostic Test Revenue by Type (2017-2028)
9.2 South America Rapid Virus Diagnostic Test Revenue by Application (2017-2028)
9.3 South America Rapid Virus Diagnostic Test Market Size by Country
9.3.1 South America Rapid Virus Diagnostic Test Revenue by Country (2017-2028)
9.3.2 Brazil Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
9.3.3 Argentina Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Rapid Virus Diagnostic Test Revenue by Type (2017-2028)
10.2 Middle East & Africa Rapid Virus Diagnostic Test Revenue by Application (2017-2028)
10.3 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Country
10.3.1 Middle East & Africa Rapid Virus Diagnostic Test Revenue by Country (2017-2028)
10.3.2 Turkey Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
10.3.4 UAE Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Rapid Virus Diagnostic Test
1.2 Classification of Rapid Virus Diagnostic Test by Type
1.2.1 Overview: Global Rapid Virus Diagnostic Test Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Rapid Virus Diagnostic Test Revenue Market Share by Type in 2021
1.2.3 Influenza
1.2.4 RSV
1.2.5 Measles
1.2.6 Rubella
1.2.7 HIV/HPV
1.2.8 Others
1.3 Global Rapid Virus Diagnostic Test Market by Application
1.3.1 Overview: Global Rapid Virus Diagnostic Test Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Global Rapid Virus Diagnostic Test Market Size & Forecast
1.5 Global Rapid Virus Diagnostic Test Market Size and Forecast by Region
1.5.1 Global Rapid Virus Diagnostic Test Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Rapid Virus Diagnostic Test Market Size by Region, (2017-2022)
1.5.3 North America Rapid Virus Diagnostic Test Market Size and Prospect (2017-2028)
1.5.4 Europe Rapid Virus Diagnostic Test Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Rapid Virus Diagnostic Test Market Size and Prospect (2017-2028)
1.5.6 South America Rapid Virus Diagnostic Test Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Rapid Virus Diagnostic Test Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Rapid Virus Diagnostic Test Market Drivers
1.6.2 Rapid Virus Diagnostic Test Market Restraints
1.6.3 Rapid Virus Diagnostic Test Trends Analysis
2 COMPANY PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Rapid Virus Diagnostic Test Product and Solutions
2.1.4 BD Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 BD Recent Developments and Future Plans
2.2 Abbot (Alere)
2.2.1 Abbot (Alere) Details
2.2.2 Abbot (Alere) Major Business
2.2.3 Abbot (Alere) Rapid Virus Diagnostic Test Product and Solutions
2.2.4 Abbot (Alere) Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbot (Alere) Recent Developments and Future Plans
2.3 Quidel
2.3.1 Quidel Details
2.3.2 Quidel Major Business
2.3.3 Quidel Rapid Virus Diagnostic Test Product and Solutions
2.3.4 Quidel Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Quidel Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Rapid Virus Diagnostic Test Product and Solutions
2.4.4 Roche Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Roche Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Rapid Virus Diagnostic Test Product and Solutions
2.5.4 Thermo Fisher Scientific Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Meridian Bioscience
2.6.1 Meridian Bioscience Details
2.6.2 Meridian Bioscience Major Business
2.6.3 Meridian Bioscience Rapid Virus Diagnostic Test Product and Solutions
2.6.4 Meridian Bioscience Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Meridian Bioscience Recent Developments and Future Plans
2.7 Analytik Jena
2.7.1 Analytik Jena Details
2.7.2 Analytik Jena Major Business
2.7.3 Analytik Jena Rapid Virus Diagnostic Test Product and Solutions
2.7.4 Analytik Jena Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Analytik Jena Recent Developments and Future Plans
2.8 Princeton BioMeditech Corporation
2.8.1 Princeton BioMeditech Corporation Details
2.8.2 Princeton BioMeditech Corporation Major Business
2.8.3 Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Product and Solutions
2.8.4 Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Princeton BioMeditech Corporation Recent Developments and Future Plans
2.9 BioMerieux
2.9.1 BioMerieux Details
2.9.2 BioMerieux Major Business
2.9.3 BioMerieux Rapid Virus Diagnostic Test Product and Solutions
2.9.4 BioMerieux Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 BioMerieux Recent Developments and Future Plans
2.10 Sekisui Diagnostics
2.10.1 Sekisui Diagnostics Details
2.10.2 Sekisui Diagnostics Major Business
2.10.3 Sekisui Diagnostics Rapid Virus Diagnostic Test Product and Solutions
2.10.4 Sekisui Diagnostics Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sekisui Diagnostics Recent Developments and Future Plans
2.11 Response Biomedical
2.11.1 Response Biomedical Details
2.11.2 Response Biomedical Major Business
2.11.3 Response Biomedical Rapid Virus Diagnostic Test Product and Solutions
2.11.4 Response Biomedical Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Response Biomedical Recent Developments and Future Plans
2.12 SA Scientific
2.12.1 SA Scientific Details
2.12.2 SA Scientific Major Business
2.12.3 SA Scientific Rapid Virus Diagnostic Test Product and Solutions
2.12.4 SA Scientific Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 SA Scientific Recent Developments and Future Plans
2.13 DiaSorin (Focus Diagnostics)
2.13.1 DiaSorin (Focus Diagnostics) Details
2.13.2 DiaSorin (Focus Diagnostics) Major Business
2.13.3 DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Product and Solutions
2.13.4 DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 DiaSorin (Focus Diagnostics) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Rapid Virus Diagnostic Test Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Rapid Virus Diagnostic Test Players Market Share in 2021
3.2.2 Top 10 Rapid Virus Diagnostic Test Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Rapid Virus Diagnostic Test Players Head Office, Products and Services Provided
3.4 Rapid Virus Diagnostic Test Mergers & Acquisitions
3.5 Rapid Virus Diagnostic Test New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Rapid Virus Diagnostic Test Revenue and Market Share by Type (2017-2022)
4.2 Global Rapid Virus Diagnostic Test Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Rapid Virus Diagnostic Test Revenue Market Share by Application (2017-2022)
5.2 Global Rapid Virus Diagnostic Test Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Rapid Virus Diagnostic Test Revenue by Type (2017-2028)
6.2 North America Rapid Virus Diagnostic Test Revenue by Application (2017-2028)
6.3 North America Rapid Virus Diagnostic Test Market Size by Country
6.3.1 North America Rapid Virus Diagnostic Test Revenue by Country (2017-2028)
6.3.2 United States Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
6.3.3 Canada Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
6.3.4 Mexico Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Rapid Virus Diagnostic Test Revenue by Type (2017-2028)
7.2 Europe Rapid Virus Diagnostic Test Revenue by Application (2017-2028)
7.3 Europe Rapid Virus Diagnostic Test Market Size by Country
7.3.1 Europe Rapid Virus Diagnostic Test Revenue by Country (2017-2028)
7.3.2 Germany Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
7.3.3 France Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
7.3.5 Russia Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
7.3.6 Italy Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Rapid Virus Diagnostic Test Revenue by Type (2017-2028)
8.2 Asia-Pacific Rapid Virus Diagnostic Test Revenue by Application (2017-2028)
8.3 Asia-Pacific Rapid Virus Diagnostic Test Market Size by Region
8.3.1 Asia-Pacific Rapid Virus Diagnostic Test Revenue by Region (2017-2028)
8.3.2 China Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8.3.3 Japan Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8.3.4 South Korea Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8.3.5 India Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
8.3.7 Australia Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Rapid Virus Diagnostic Test Revenue by Type (2017-2028)
9.2 South America Rapid Virus Diagnostic Test Revenue by Application (2017-2028)
9.3 South America Rapid Virus Diagnostic Test Market Size by Country
9.3.1 South America Rapid Virus Diagnostic Test Revenue by Country (2017-2028)
9.3.2 Brazil Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
9.3.3 Argentina Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Rapid Virus Diagnostic Test Revenue by Type (2017-2028)
10.2 Middle East & Africa Rapid Virus Diagnostic Test Revenue by Application (2017-2028)
10.3 Middle East & Africa Rapid Virus Diagnostic Test Market Size by Country
10.3.1 Middle East & Africa Rapid Virus Diagnostic Test Revenue by Country (2017-2028)
10.3.2 Turkey Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
10.3.4 UAE Rapid Virus Diagnostic Test Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Rapid Virus Diagnostic Test Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Rapid Virus Diagnostic Test Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Rapid Virus Diagnostic Test Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Rapid Virus Diagnostic Test Revenue (USD Million) by Region (2017-2022)
Table 5. Global Rapid Virus Diagnostic Test Revenue Market Share by Region (2023-2028)
Table 6. BD Corporate Information, Head Office, and Major Competitors
Table 7. BD Major Business
Table 8. BD Rapid Virus Diagnostic Test Product and Solutions
Table 9. BD Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbot (Alere) Corporate Information, Head Office, and Major Competitors
Table 11. Abbot (Alere) Major Business
Table 12. Abbot (Alere) Rapid Virus Diagnostic Test Product and Solutions
Table 13. Abbot (Alere) Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Quidel Corporate Information, Head Office, and Major Competitors
Table 15. Quidel Major Business
Table 16. Quidel Rapid Virus Diagnostic Test Product and Solutions
Table 17. Quidel Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Rapid Virus Diagnostic Test Product and Solutions
Table 21. Roche Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific Major Business
Table 24. Thermo Fisher Scientific Rapid Virus Diagnostic Test Product and Solutions
Table 25. Thermo Fisher Scientific Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Meridian Bioscience Corporate Information, Head Office, and Major Competitors
Table 27. Meridian Bioscience Major Business
Table 28. Meridian Bioscience Rapid Virus Diagnostic Test Product and Solutions
Table 29. Meridian Bioscience Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Analytik Jena Corporate Information, Head Office, and Major Competitors
Table 31. Analytik Jena Major Business
Table 32. Analytik Jena Rapid Virus Diagnostic Test Product and Solutions
Table 33. Analytik Jena Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Princeton BioMeditech Corporation Corporate Information, Head Office, and Major Competitors
Table 35. Princeton BioMeditech Corporation Major Business
Table 36. Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Product and Solutions
Table 37. Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 39. BioMerieux Major Business
Table 40. BioMerieux Rapid Virus Diagnostic Test Product and Solutions
Table 41. BioMerieux Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sekisui Diagnostics Corporate Information, Head Office, and Major Competitors
Table 43. Sekisui Diagnostics Major Business
Table 44. Sekisui Diagnostics Rapid Virus Diagnostic Test Product and Solutions
Table 45. Sekisui Diagnostics Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Response Biomedical Corporate Information, Head Office, and Major Competitors
Table 47. Response Biomedical Major Business
Table 48. Response Biomedical Rapid Virus Diagnostic Test Product and Solutions
Table 49. Response Biomedical Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. SA Scientific Corporate Information, Head Office, and Major Competitors
Table 51. SA Scientific Major Business
Table 52. SA Scientific Rapid Virus Diagnostic Test Product and Solutions
Table 53. SA Scientific Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. DiaSorin (Focus Diagnostics) Corporate Information, Head Office, and Major Competitors
Table 55. DiaSorin (Focus Diagnostics) Major Business
Table 56. DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Product and Solutions
Table 57. DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Rapid Virus Diagnostic Test Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Rapid Virus Diagnostic Test Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Rapid Virus Diagnostic Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Rapid Virus Diagnostic Test Players Head Office, Products and Services Provided
Table 62. Rapid Virus Diagnostic Test Mergers & Acquisitions in the Past Five Years
Table 63. Rapid Virus Diagnostic Test New Entrants and Expansion Plans
Table 64. Global Rapid Virus Diagnostic Test Revenue (USD Million) by Type (2017-2022)
Table 65. Global Rapid Virus Diagnostic Test Revenue Share by Type (2017-2022)
Table 66. Global Rapid Virus Diagnostic Test Revenue Forecast by Type (2023-2028)
Table 67. Global Rapid Virus Diagnostic Test Revenue by Application (2017-2022)
Table 68. Global Rapid Virus Diagnostic Test Revenue Forecast by Application (2023-2028)
Table 69. North America Rapid Virus Diagnostic Test Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Rapid Virus Diagnostic Test Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Rapid Virus Diagnostic Test Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Rapid Virus Diagnostic Test Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Rapid Virus Diagnostic Test Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Rapid Virus Diagnostic Test Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Rapid Virus Diagnostic Test Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Rapid Virus Diagnostic Test Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Rapid Virus Diagnostic Test Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Rapid Virus Diagnostic Test Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Rapid Virus Diagnostic Test Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Rapid Virus Diagnostic Test Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Rapid Virus Diagnostic Test Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Rapid Virus Diagnostic Test Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Rapid Virus Diagnostic Test Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Rapid Virus Diagnostic Test Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Rapid Virus Diagnostic Test Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Rapid Virus Diagnostic Test Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Rapid Virus Diagnostic Test Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Rapid Virus Diagnostic Test Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Rapid Virus Diagnostic Test Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Rapid Virus Diagnostic Test Revenue (USD Million) by Region (2017-2022)
Table 5. Global Rapid Virus Diagnostic Test Revenue Market Share by Region (2023-2028)
Table 6. BD Corporate Information, Head Office, and Major Competitors
Table 7. BD Major Business
Table 8. BD Rapid Virus Diagnostic Test Product and Solutions
Table 9. BD Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbot (Alere) Corporate Information, Head Office, and Major Competitors
Table 11. Abbot (Alere) Major Business
Table 12. Abbot (Alere) Rapid Virus Diagnostic Test Product and Solutions
Table 13. Abbot (Alere) Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Quidel Corporate Information, Head Office, and Major Competitors
Table 15. Quidel Major Business
Table 16. Quidel Rapid Virus Diagnostic Test Product and Solutions
Table 17. Quidel Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Rapid Virus Diagnostic Test Product and Solutions
Table 21. Roche Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific Major Business
Table 24. Thermo Fisher Scientific Rapid Virus Diagnostic Test Product and Solutions
Table 25. Thermo Fisher Scientific Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Meridian Bioscience Corporate Information, Head Office, and Major Competitors
Table 27. Meridian Bioscience Major Business
Table 28. Meridian Bioscience Rapid Virus Diagnostic Test Product and Solutions
Table 29. Meridian Bioscience Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Analytik Jena Corporate Information, Head Office, and Major Competitors
Table 31. Analytik Jena Major Business
Table 32. Analytik Jena Rapid Virus Diagnostic Test Product and Solutions
Table 33. Analytik Jena Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Princeton BioMeditech Corporation Corporate Information, Head Office, and Major Competitors
Table 35. Princeton BioMeditech Corporation Major Business
Table 36. Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Product and Solutions
Table 37. Princeton BioMeditech Corporation Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 39. BioMerieux Major Business
Table 40. BioMerieux Rapid Virus Diagnostic Test Product and Solutions
Table 41. BioMerieux Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sekisui Diagnostics Corporate Information, Head Office, and Major Competitors
Table 43. Sekisui Diagnostics Major Business
Table 44. Sekisui Diagnostics Rapid Virus Diagnostic Test Product and Solutions
Table 45. Sekisui Diagnostics Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Response Biomedical Corporate Information, Head Office, and Major Competitors
Table 47. Response Biomedical Major Business
Table 48. Response Biomedical Rapid Virus Diagnostic Test Product and Solutions
Table 49. Response Biomedical Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. SA Scientific Corporate Information, Head Office, and Major Competitors
Table 51. SA Scientific Major Business
Table 52. SA Scientific Rapid Virus Diagnostic Test Product and Solutions
Table 53. SA Scientific Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. DiaSorin (Focus Diagnostics) Corporate Information, Head Office, and Major Competitors
Table 55. DiaSorin (Focus Diagnostics) Major Business
Table 56. DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Product and Solutions
Table 57. DiaSorin (Focus Diagnostics) Rapid Virus Diagnostic Test Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Rapid Virus Diagnostic Test Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Rapid Virus Diagnostic Test Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Rapid Virus Diagnostic Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Rapid Virus Diagnostic Test Players Head Office, Products and Services Provided
Table 62. Rapid Virus Diagnostic Test Mergers & Acquisitions in the Past Five Years
Table 63. Rapid Virus Diagnostic Test New Entrants and Expansion Plans
Table 64. Global Rapid Virus Diagnostic Test Revenue (USD Million) by Type (2017-2022)
Table 65. Global Rapid Virus Diagnostic Test Revenue Share by Type (2017-2022)
Table 66. Global Rapid Virus Diagnostic Test Revenue Forecast by Type (2023-2028)
Table 67. Global Rapid Virus Diagnostic Test Revenue by Application (2017-2022)
Table 68. Global Rapid Virus Diagnostic Test Revenue Forecast by Application (2023-2028)
Table 69. North America Rapid Virus Diagnostic Test Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Rapid Virus Diagnostic Test Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Rapid Virus Diagnostic Test Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Rapid Virus Diagnostic Test Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Rapid Virus Diagnostic Test Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Rapid Virus Diagnostic Test Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Rapid Virus Diagnostic Test Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Rapid Virus Diagnostic Test Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Rapid Virus Diagnostic Test Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Rapid Virus Diagnostic Test Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Rapid Virus Diagnostic Test Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Rapid Virus Diagnostic Test Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Rapid Virus Diagnostic Test Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Rapid Virus Diagnostic Test Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Rapid Virus Diagnostic Test Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Rapid Virus Diagnostic Test Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Rapid Virus Diagnostic Test Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Rapid Virus Diagnostic Test Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Rapid Virus Diagnostic Test Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Rapid Virus Diagnostic Test Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Rapid Virus Diagnostic Test Picture
Figure 2. Global Rapid Virus Diagnostic Test Revenue Market Share by Type in 2021
Figure 3. Influenza
Figure 4. RSV
Figure 5. Measles
Figure 6. Rubella
Figure 7. HIV/HPV
Figure 8. Others
Figure 9. Rapid Virus Diagnostic Test Revenue Market Share by Application in 2021
Figure 10. Hospitals Picture
Figure 11. POCT Picture
Figure 12. Others Picture
Figure 13. Global Rapid Virus Diagnostic Test Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Rapid Virus Diagnostic Test Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Rapid Virus Diagnostic Test Revenue Market Share by Region (2017-2028)
Figure 16. Global Rapid Virus Diagnostic Test Revenue Market Share by Region in 2021
Figure 17. North America Rapid Virus Diagnostic Test Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Rapid Virus Diagnostic Test Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Rapid Virus Diagnostic Test Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Rapid Virus Diagnostic Test Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Rapid Virus Diagnostic Test Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Rapid Virus Diagnostic Test Market Drivers
Figure 23. Rapid Virus Diagnostic Test Market Restraints
Figure 24. Rapid Virus Diagnostic Test Market Trends
Figure 25. BD Recent Developments and Future Plans
Figure 26. Abbot (Alere) Recent Developments and Future Plans
Figure 27. Quidel Recent Developments and Future Plans
Figure 28. Roche Recent Developments and Future Plans
Figure 29. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 30. Meridian Bioscience Recent Developments and Future Plans
Figure 31. Analytik Jena Recent Developments and Future Plans
Figure 32. Princeton BioMeditech Corporation Recent Developments and Future Plans
Figure 33. BioMerieux Recent Developments and Future Plans
Figure 34. Sekisui Diagnostics Recent Developments and Future Plans
Figure 35. Response Biomedical Recent Developments and Future Plans
Figure 36. SA Scientific Recent Developments and Future Plans
Figure 37. DiaSorin (Focus Diagnostics) Recent Developments and Future Plans
Figure 38. Global Rapid Virus Diagnostic Test Revenue Share by Players in 2021
Figure 39. Rapid Virus Diagnostic Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Rapid Virus Diagnostic Test Revenue Market Share in 2021
Figure 41. Global Top 10 Players Rapid Virus Diagnostic Test Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Rapid Virus Diagnostic Test Revenue Share by Type in 2021
Figure 44. Global Rapid Virus Diagnostic Test Market Share Forecast by Type (2023-2028)
Figure 45. Global Rapid Virus Diagnostic Test Revenue Share by Application in 2021
Figure 46. Global Rapid Virus Diagnostic Test Market Share Forecast by Application (2023-2028)
Figure 47. North America Rapid Virus Diagnostic Test Sales Market Share by Type (2017-2028)
Figure 48. North America Rapid Virus Diagnostic Test Sales Market Share by Application (2017-2028)
Figure 49. North America Rapid Virus Diagnostic Test Revenue Market Share by Country (2017-2028)
Figure 50. United States Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Rapid Virus Diagnostic Test Sales Market Share by Type (2017-2028)
Figure 54. Europe Rapid Virus Diagnostic Test Sales Market Share by Application (2017-2028)
Figure 55. Europe Rapid Virus Diagnostic Test Revenue Market Share by Country (2017-2028)
Figure 56. Germany Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Rapid Virus Diagnostic Test Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Rapid Virus Diagnostic Test Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Rapid Virus Diagnostic Test Revenue Market Share by Region (2017-2028)
Figure 64. China Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Rapid Virus Diagnostic Test Sales Market Share by Type (2017-2028)
Figure 71. South America Rapid Virus Diagnostic Test Sales Market Share by Application (2017-2028)
Figure 72. South America Rapid Virus Diagnostic Test Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Rapid Virus Diagnostic Test Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Rapid Virus Diagnostic Test Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Rapid Virus Diagnostic Test Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Figure 1. Rapid Virus Diagnostic Test Picture
Figure 2. Global Rapid Virus Diagnostic Test Revenue Market Share by Type in 2021
Figure 3. Influenza
Figure 4. RSV
Figure 5. Measles
Figure 6. Rubella
Figure 7. HIV/HPV
Figure 8. Others
Figure 9. Rapid Virus Diagnostic Test Revenue Market Share by Application in 2021
Figure 10. Hospitals Picture
Figure 11. POCT Picture
Figure 12. Others Picture
Figure 13. Global Rapid Virus Diagnostic Test Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Rapid Virus Diagnostic Test Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Rapid Virus Diagnostic Test Revenue Market Share by Region (2017-2028)
Figure 16. Global Rapid Virus Diagnostic Test Revenue Market Share by Region in 2021
Figure 17. North America Rapid Virus Diagnostic Test Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Rapid Virus Diagnostic Test Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Rapid Virus Diagnostic Test Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Rapid Virus Diagnostic Test Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Rapid Virus Diagnostic Test Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Rapid Virus Diagnostic Test Market Drivers
Figure 23. Rapid Virus Diagnostic Test Market Restraints
Figure 24. Rapid Virus Diagnostic Test Market Trends
Figure 25. BD Recent Developments and Future Plans
Figure 26. Abbot (Alere) Recent Developments and Future Plans
Figure 27. Quidel Recent Developments and Future Plans
Figure 28. Roche Recent Developments and Future Plans
Figure 29. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 30. Meridian Bioscience Recent Developments and Future Plans
Figure 31. Analytik Jena Recent Developments and Future Plans
Figure 32. Princeton BioMeditech Corporation Recent Developments and Future Plans
Figure 33. BioMerieux Recent Developments and Future Plans
Figure 34. Sekisui Diagnostics Recent Developments and Future Plans
Figure 35. Response Biomedical Recent Developments and Future Plans
Figure 36. SA Scientific Recent Developments and Future Plans
Figure 37. DiaSorin (Focus Diagnostics) Recent Developments and Future Plans
Figure 38. Global Rapid Virus Diagnostic Test Revenue Share by Players in 2021
Figure 39. Rapid Virus Diagnostic Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Rapid Virus Diagnostic Test Revenue Market Share in 2021
Figure 41. Global Top 10 Players Rapid Virus Diagnostic Test Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Rapid Virus Diagnostic Test Revenue Share by Type in 2021
Figure 44. Global Rapid Virus Diagnostic Test Market Share Forecast by Type (2023-2028)
Figure 45. Global Rapid Virus Diagnostic Test Revenue Share by Application in 2021
Figure 46. Global Rapid Virus Diagnostic Test Market Share Forecast by Application (2023-2028)
Figure 47. North America Rapid Virus Diagnostic Test Sales Market Share by Type (2017-2028)
Figure 48. North America Rapid Virus Diagnostic Test Sales Market Share by Application (2017-2028)
Figure 49. North America Rapid Virus Diagnostic Test Revenue Market Share by Country (2017-2028)
Figure 50. United States Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Rapid Virus Diagnostic Test Sales Market Share by Type (2017-2028)
Figure 54. Europe Rapid Virus Diagnostic Test Sales Market Share by Application (2017-2028)
Figure 55. Europe Rapid Virus Diagnostic Test Revenue Market Share by Country (2017-2028)
Figure 56. Germany Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Rapid Virus Diagnostic Test Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Rapid Virus Diagnostic Test Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Rapid Virus Diagnostic Test Revenue Market Share by Region (2017-2028)
Figure 64. China Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Rapid Virus Diagnostic Test Sales Market Share by Type (2017-2028)
Figure 71. South America Rapid Virus Diagnostic Test Sales Market Share by Application (2017-2028)
Figure 72. South America Rapid Virus Diagnostic Test Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Rapid Virus Diagnostic Test Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Rapid Virus Diagnostic Test Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Rapid Virus Diagnostic Test Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Rapid Virus Diagnostic Test Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
